Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients
暂无分享,去创建一个
P. Stenvinkel | B. Lindholm | A. Qureshi | T. Brismar | C. Avesani | P. Bárány | O. Heimbürger | M. Suliman | J. Ripsweden | Zhimin Chen | Kakei Ryu
[1] Kyunghwa Han,et al. Restricted Mean Survival Time for Survival Analysis: A Quick Guide for Clinical Researchers , 2022, Korean journal of radiology.
[2] P. Chiarello,et al. Sarcopenic Obesity in Chronic Kidney Disease: Challenges in Diagnosis Using Different Diagnostic Criteria , 2021, Medical Principles and Practice.
[3] D. Berman,et al. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. , 2021, Atherosclerosis.
[4] A. Jayedi,et al. Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies , 2020, BMJ.
[5] J. Krakauer,et al. Association of Body Shape Index (ABSI) with Hand Grip Strength , 2020, International journal of environmental research and public health.
[6] F. Hu,et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity , 2020, Nature Reviews Endocrinology.
[7] P. Stenvinkel,et al. Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease. , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] L. Tereshchenko,et al. Association of Abdominal Adiposity with Cardiovascular Mortality in Incident Hemodialysis , 2018, American Journal of Nephrology.
[9] Y. Zha,et al. Visceral, general, abdominal adiposity and atherogenic index of plasma in relatively lean hemodialysis patients , 2018, BMC Nephrology.
[10] A. Balbi,et al. Handgrip strength in end stage of renal disease—a narrative review , 2018, Nutrire.
[11] Youngmee Kim,et al. Obesity and chronic kidney disease: A population-based study among South Koreans , 2018, PloS one.
[12] J. Caramori,et al. Recognition of visceral obesity beyond body fat: assessment of cardiovascular risk in chronic kidney disease using anthropometry , 2017, Nutrire.
[13] C. Zoccali,et al. Obesity and kidney disease: hidden consequences of the epidemic , 2017, Journal of Nephrology.
[14] O. Mohamed,et al. Central obesity and risks of cardiovascular events and mortality in prevalent hemodialysis patients , 2017, International Urology and Nephrology.
[15] C. Zoccali,et al. Obesity and Kidney Disease: Hidden Consequences of the Epidemic. , 2017, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[16] Ó. Escribano,et al. Differential Role of Adipose Tissues in Obesity and Related Metabolic and Vascular Complications , 2016, International journal of endocrinology.
[17] J. Carrero,et al. Sensitivity and Specificity of Body Mass Index as a Marker of Obesity in Elderly Patients on Hemodialysis. , 2016, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[18] C. Prado,et al. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact , 2016, Proceedings of the Nutrition Society.
[19] P. Stenvinkel,et al. Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification. , 2015, Kidney international.
[20] F. Zamani,et al. Conicity Index and Waist‐to‐Hip Ratio Are Superior Obesity Indices in Predicting 10‐Year Cardiovascular Risk Among Men and Women , 2015, Clinical cardiology.
[21] J. Carrero,et al. Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients , 2015, Peritoneal Dialysis International.
[22] F. Nuttall,et al. Body Mass Index , 2020, Definitions.
[23] M. Malara,et al. Body shape index versus body mass index as correlates of health risk in young healthy sedentary men , 2015, Journal of Translational Medicine.
[24] F. Nuttall. Body Mass Index , 2015, Nutrition today.
[25] F. Hu,et al. The Epidemiology of Obesity: A Big Picture , 2015, PharmacoEconomics.
[26] P. Raggi,et al. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. , 2014, Atherosclerosis.
[27] T. Ikizler,et al. Obesity in CKD--what should nephrologists know? , 2013, Journal of the American Society of Nephrology : JASN.
[28] J. Carrero,et al. Visceral fat and coronary artery calcification in patients with chronic kidney disease. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[29] G. Barril,et al. Conicity index as a contributor marker of inflammation in haemodialysis patients. , 2013, Nutricion hospitalaria.
[30] R. V. van Domburg,et al. Obesity, health status, and 7-year mortality in percutaneous coronary intervention: in search of an explanation for the obesity paradox. , 2013, International journal of cardiology.
[31] Teresa Oliveira,et al. Biochemistry of adipose tissue: an endocrine organ , 2013, Archives of medical science : AMS.
[32] H. Kramer,et al. Obesity and kidney disease: potential mechanisms. , 2013, Seminars in nephrology.
[33] J. Krakauer,et al. A New Body Shape Index Predicts Mortality Hazard Independently of Body Mass Index , 2012, PloS one.
[34] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[35] Antonio Pflüger,et al. Executive Summary. , 2012, Journal of the ICRU.
[36] Yong Zhou,et al. Comparison of different anthropometric measures as predictors of diabetes incidence in a Chinese population. , 2011, Diabetes research and clinical practice.
[37] W. Brown. Framingham Heart Study. , 2011, Journal of clinical lipidology.
[38] R. Agarwal,et al. Diagnosing Obesity by Body Mass Index in Chronic Kidney Disease: An Explanation for the “Obesity Paradox?” , 2010, Hypertension.
[39] J. Carrero,et al. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[40] C. Zoccali,et al. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. , 2009, Journal of the American College of Cardiology.
[41] M. Schulze,et al. General and abdominal adiposity and risk of death in Europe. , 2008, The New England journal of medicine.
[42] J. Axelsson,et al. Waist circumference and visceral fat in CKD: a cross-sectional study. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[43] J. Griffith,et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[44] J. Griffith,et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[45] C. Lewis,et al. Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects. , 2008, The American journal of clinical nutrition.
[46] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[47] Pedagógia,et al. Cross Sectional Study , 2019 .
[48] A. Garg,et al. Chronic kidney disease and mortality risk: a systematic review. , 2006, Journal of the American Society of Nephrology : JASN.
[49] A. Luke,et al. Increasing body mass index and obesity in the incident ESRD population. , 2006, Journal of the American Society of Nephrology : JASN.
[50] S. Ferreira,et al. Gordura visceral e sndrome metablica: mais que uma simples associao , 2006 .
[51] S. R. Ferreira,et al. [Visceral fat and metabolic syndrome: more than a simple association]. , 2006, Arquivos brasileiros de endocrinologia e metabologia.
[52] Y. Hu,et al. Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[53] J. Frohlich,et al. [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy]. , 2000, Vnitrni lekarstvi.
[54] B. Burmahl. The big picture. , 2000, Health facilities management.
[55] P. Stenvinkel,et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. , 1999, Kidney international.
[56] B. Lindholm,et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. , 1998, Kidney international.
[57] Claude Bouchard,et al. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary , 1998 .
[58] K. Weiss,et al. A new index of abdominal adiposity as an indicator of risk for cardiovascular disease. A cross-population study. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[59] R. Detrano,et al. Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.
[60] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.